Cargando…

2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD

BACKGROUND: Steroid refractory acute graft- vs. -host-disease (GVHD) after hematopoietic cell transplantation (HCT) is highly morbid with limited treatment options. Murine studies show protection from GVHD with butyrate exposure but direct exposure of stem/progenitor cells to butyrate inhibits colon...

Descripción completa

Detalles Bibliográficos
Autores principales: Golob, Jonathan L, DeMeules, Martha M, Loeffelholz, Tillie, Quinn, Z Z, Dame, Michael K, Silvestri, Sabrina, Wu, Michael, Schmidt, Tom, Fiedler, Tina L, Hoostal, Matthew, Mielcarek, Marco, Spence, Jason, Pergam, Steven A, Fredricks, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808863/
http://dx.doi.org/10.1093/ofid/ofz359.149
_version_ 1783461840668327936
author Golob, Jonathan L
DeMeules, Martha M
Loeffelholz, Tillie
Quinn, Z Z
Dame, Michael K
Silvestri, Sabrina
Wu, Michael
Schmidt, Tom
Fiedler, Tina L
Hoostal, Matthew
Mielcarek, Marco
Spence, Jason
Pergam, Steven A
Fredricks, David
author_facet Golob, Jonathan L
DeMeules, Martha M
Loeffelholz, Tillie
Quinn, Z Z
Dame, Michael K
Silvestri, Sabrina
Wu, Michael
Schmidt, Tom
Fiedler, Tina L
Hoostal, Matthew
Mielcarek, Marco
Spence, Jason
Pergam, Steven A
Fredricks, David
author_sort Golob, Jonathan L
collection PubMed
description BACKGROUND: Steroid refractory acute graft- vs. -host-disease (GVHD) after hematopoietic cell transplantation (HCT) is highly morbid with limited treatment options. Murine studies show protection from GVHD with butyrate exposure but direct exposure of stem/progenitor cells to butyrate inhibits colonic stem cell proliferation. METHODS: Stool samples were collected weekly in a cohort of HCT recipients (n = 210) undergoing allogeneic transplant, and underwent 16S rRNA sequencing to determine the number and relative abundance of butyrogens. Dissociated primary human colonoid cell aggregates (200,000 per well) were plated onto collagen IV-coated transwells (0.4 µm pore size, 0.33 cm(2), PET) in stem cell medium for 24 hours. From 24 hours onwards, the basal-lateral chamber was switched to differentiation medium; the apical chamber was Hanks Buffered Salt Solution (HBSS), HBSS with 10 mM butyrate sodium salt early (24 hours onwards) or late (72hours onwards). Trans-epithelial electrical resistance was measured daily. RESULTS: Retrospective chart review identified 27 recipients who developed acute GVHD of the gut, stratified to be either steroid refractory GVHD (failed to respond to 2 mg/kg of methylprednisolone) or responsive. The presence of butyrogens in the gut microbiome after the onset of severe acute GHVD of the gut associated with increased risk of steroid refractory GVHD (Figure 1; P < 0.05). Direct exposure of human colonic stem/progenitor cells to butyrate inhibits the development of trans-epithelial electrical resistance; exposure after differentiation had no inhibition of barrier formation (Figure 2; P < 0.05 by T-test). CONCLUSION: Butyrogens may help prevent the development of acute GVHD of the gut, but once severe GVHD has developed may inhibit recovery due to the loss of crypt architecture exposing colonic stem cells to microbe-produced butyrate with impaired differentiation and cell replacement. [Image: see text] [Image: see text] DISCLOSURES: All Authors: No reported Disclosures.
format Online
Article
Text
id pubmed-6808863
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68088632019-10-28 2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD Golob, Jonathan L DeMeules, Martha M Loeffelholz, Tillie Quinn, Z Z Dame, Michael K Silvestri, Sabrina Wu, Michael Schmidt, Tom Fiedler, Tina L Hoostal, Matthew Mielcarek, Marco Spence, Jason Pergam, Steven A Fredricks, David Open Forum Infect Dis Abstracts BACKGROUND: Steroid refractory acute graft- vs. -host-disease (GVHD) after hematopoietic cell transplantation (HCT) is highly morbid with limited treatment options. Murine studies show protection from GVHD with butyrate exposure but direct exposure of stem/progenitor cells to butyrate inhibits colonic stem cell proliferation. METHODS: Stool samples were collected weekly in a cohort of HCT recipients (n = 210) undergoing allogeneic transplant, and underwent 16S rRNA sequencing to determine the number and relative abundance of butyrogens. Dissociated primary human colonoid cell aggregates (200,000 per well) were plated onto collagen IV-coated transwells (0.4 µm pore size, 0.33 cm(2), PET) in stem cell medium for 24 hours. From 24 hours onwards, the basal-lateral chamber was switched to differentiation medium; the apical chamber was Hanks Buffered Salt Solution (HBSS), HBSS with 10 mM butyrate sodium salt early (24 hours onwards) or late (72hours onwards). Trans-epithelial electrical resistance was measured daily. RESULTS: Retrospective chart review identified 27 recipients who developed acute GVHD of the gut, stratified to be either steroid refractory GVHD (failed to respond to 2 mg/kg of methylprednisolone) or responsive. The presence of butyrogens in the gut microbiome after the onset of severe acute GHVD of the gut associated with increased risk of steroid refractory GVHD (Figure 1; P < 0.05). Direct exposure of human colonic stem/progenitor cells to butyrate inhibits the development of trans-epithelial electrical resistance; exposure after differentiation had no inhibition of barrier formation (Figure 2; P < 0.05 by T-test). CONCLUSION: Butyrogens may help prevent the development of acute GVHD of the gut, but once severe GVHD has developed may inhibit recovery due to the loss of crypt architecture exposing colonic stem cells to microbe-produced butyrate with impaired differentiation and cell replacement. [Image: see text] [Image: see text] DISCLOSURES: All Authors: No reported Disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6808863/ http://dx.doi.org/10.1093/ofid/ofz359.149 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Golob, Jonathan L
DeMeules, Martha M
Loeffelholz, Tillie
Quinn, Z Z
Dame, Michael K
Silvestri, Sabrina
Wu, Michael
Schmidt, Tom
Fiedler, Tina L
Hoostal, Matthew
Mielcarek, Marco
Spence, Jason
Pergam, Steven A
Fredricks, David
2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD
title 2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD
title_full 2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD
title_fullStr 2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD
title_full_unstemmed 2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD
title_short 2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD
title_sort 2844. butyrogenic bacteria after acute graft vs. host disease associate with the development of steroid refractory gvhd
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808863/
http://dx.doi.org/10.1093/ofid/ofz359.149
work_keys_str_mv AT golobjonathanl 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd
AT demeulesmartham 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd
AT loeffelholztillie 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd
AT quinnzz 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd
AT damemichaelk 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd
AT silvestrisabrina 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd
AT wumichael 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd
AT schmidttom 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd
AT fiedlertinal 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd
AT hoostalmatthew 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd
AT mielcarekmarco 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd
AT spencejason 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd
AT pergamstevena 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd
AT fredricksdavid 2844butyrogenicbacteriaafteracutegraftvshostdiseaseassociatewiththedevelopmentofsteroidrefractorygvhd